NeoPhore

Cambridge, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

May 2024

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are NeoPhore's investors?

NeoPhore's investors include Neva SGR, Bristol-Myers Squibb, Innovate UK, LIFTT, Claris Ventures.

Where is NeoPhore headquartered?

NeoPhore is headquartered in Cambridge, United Kingdom.

What does NeoPhore do?

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

What stage is NeoPhore at?

NeoPhore is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 22, 2024.

MLA

"NeoPhore — Funding & Investors." VCBacked, May 22, 2024, https://www.vcbacked.co/company/neophore. Accessed July 2, 2026.

APA

VCBacked. (2024). NeoPhore — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neophore

Wikipedia (cite web)

{{cite web |title=NeoPhore — Funding & Investors |url=https://www.vcbacked.co/company/neophore |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 22, 2024.